Pentwater Capital Management LP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 70 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 1.0%.

Quarter-by-quarter ownership
Pentwater Capital Management LP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$760,000
+85.8%
400,000
+2896.3%
0.01%
+333.3%
Q3 2018$409,000
+1.7%
13,350
-11.0%
0.00%0.0%
Q2 2018$402,00015,0000.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders